Pupillary dilatation is potentially dangerous, since a variable proportion of eyes at risk to closed-angle glaucoma develop a rise in pressure of 8 mmHg or more. A much smaller percentage of narrow-angle eyes with no relevant history will respond similarly. Given a particular eye with a narrow angle, how can the dangers be minimised if the pupil must be dilated?
Gonioscopy is of no help, since it gives a subjective assessment of grades of narrowness. While it is intuitively obvious that the narrower the angle the greater is the probability of closure, there is no published evidence to show that angle appearance is a reliable indicator of future behaviour on dilatation.
The most that can be known before dilating a particular pupil is that there exists a certain probability that that eye will develop closed-angle glaucoma. Anyone who dilates pupils therefore is taking a chance.
Given this situation, the clinician has two options. Firstly, he can accept that a risk is present, explain it, measure it, and devise a scheme for treating the eye that develops closed-angle glaucoma so that any possible damage is, reduced to a minimum. Secondly, he can refuse to accept the risk and devise a method whereby any pupil can be safely dilated. Both options are explored in this paper.
Material and methods
(1) Twenty-one eyes at risk to the development of closed-angle glaucoma (because the contralateral eye had had an episode of acute closed-angle glaucoma) were on no treatment. All had been previously provoked with simultaneous pilocarpine and phenylephrine, and 17 had positive provocative tests (that is, a pressure increase of greater than 8 mmHg).
They were reprovoked as follows: At zero hours an anterior segment photograph was taken, intraocular pressure measured, and one drop of cyclopentolate I % instilled. Thereafter given, but even after 51 hours the mean pressure was still 25-3 mmHg. In addition pupil diameter was little affected.
(b) In 2 eyes the pupil moved rapidly up to wide dilatation and there remained for 3 hours with no change in pressure. As the pupil moved down to mid-dilatation pressure increased significantly. An example is shown in Fig. 3 .
(c) In 3 eyes the pattern of response was a combination of a and b. As the pupil moved up to group.bmj.com on October 14, 2017 -Published by http://bjo.bmj.com/ Downloaded from C P P P IVA t P T occurs as the pupil moves up to wide dilatation. In that positition pressure falls to normal levels, rising again as the pupil moves down to mid-dilatation. C = cyclopentolate, P = pilocarpine, T= thymoxamine, IVA = intravenous acetazolamide wide dilatation a significant increase in pressure occurred (from a mean of 14-3 to a mean of 23 mmHg- Fig. 4 ). At wide dilatation pressure fell to normal, and as the pupil moved down towards middilatation pressure again increased. One patient is described in detail: Female age 56, no symptoms, but her mother had closed-angle glaucoma. Provocative tests in this patient with pilocarpine and phenylephrine were negative but with tropicamide positive (see Mapstone, 1976b) . She was reprovoked with cyclopentolate, with the result shown in Fig. 5 . As the pupil moved up to wide dilatation outflow fell from 0 19 to 0 07; 21 hours later pressure was 14 mmHg and the corneal diameter had increased to 0-31. However, 5! hours after the start of the test the corneal diameter had decreased to 0-02 and pressure increased to 42 mmHg.
EYES DILATED WITH TROPICAMIDE
Thirty-nine eyes developed no significant increase in pressure measured over a 2-hour period (Fig. 6 ).
The instillation of pilocarpine 2% at this point produced a fall in pupil diameter over the next hour.
Nineteen eyes developed a significant increase in pressure. Fig. 7 records the results and shows that after 45 minutes pressure increased from a mean of 17-9 to a mean of 30-4 mmHg. These eyes were left untreated for an average of 30 minutes. Intravenous acetazolamide 500 mg and pilocarpine 2% returned the pressure of all eyes to normal within 1 hours.
In 9 eyes outflow facility was measured at the start of the test and at the first recorded significant increase in pressure. The results are recorded in Table 1 Given a suitably predisposed anterior segment two main variables determine the development of angle closure-namely, pupil diameter and the size of the pupil block force. The variation of the sphincter pupil block force during normal pupillary activity is shown in Fig. 9 (Mapstone, 1974c) . It is apparent that a pupil can attain three main positions: (1) Miosis with a taut iris and small pupil block force; (2) mid-dilatation with a lax iris and large pupil block force; (3) wide dilatation with a compressed iris and small pupil block force. Experimentally, (1) and (3) are not associated with angle closure, while (2) is the position of greatest risk (Mapstone, 1974a, b, c) .
Figs. 10 and 11 illustrate events that can happen during pupillary dilatation and subsequent miosis. If a weak dilator drug is used (Fig. 10) With this as a model the patterns of behaviour described in the results can be interpreted as follows:
(1) The pupil moves from miosis to wide dilatation and back to miosis with no significant change in pressure. Twelve eyes dilated with cyclopentolate behaved in this manner (Fig. 1 ). It has also been shown that pupils at risk dilated with phenylephrine and then miosed with thymoxamine show a similar response (Mapstone, 1974b) . Some pupils dilated with tropicamide behaved in a like manner, others moved to mid-dilatation and then back to miosis, with 67 % of the total showing no significant increase in pressure (Fig. 6) . At no stage, therefore, did these eyes develop sufficient angle closure for a sufficient period to produce a significant pressure rise.
(2) The pupil moves from miosis to mid-dilatation, during which sufficient of the angle closes to produce a significant pressure increase (Fig. 12) . Four eyes dilated with cyclopentolate ( Fig. 2) and 19 eyes dilated with tropicamide (Fig. 7) (Fig. 6) . The practical consequence is that if an eye at risk develops closed-angle glaucoma by dilatation with tropicamide it will do so within the first hour.
If after that time pressure has not increased significantly, it is safe to dismiss the patient with no treatment. Miotics are unnecessary and may even precipitate angle closure in mid-dilatation (the significance of angle closure precipitated by pilocarpine in this situation has been discussed elsewhere (Mapstone, 1974 (Mapstone, , 1976 ).
(3) The pupil moves rapidly (within 1 hour) from miosis to wide dilatation with no increase in pressure. Movement of the pupil back to mid-dilatation with pilocarpine produces angle closure and a significant increase in pressure (Fig. 13) . Further treatment then moves the pupil back to miosis, the angle opens, and pressure falls. This pattern occurred in two situations: (a) Two eyes dilated with cyclopentolate (Fig. 3) developed a raised pressure as the pupil moved down to mid-dilatation with pilocarpine. Further treatment brought pressure back to normal. (b) Six eyes dilated with phenylephrine moved rapidly from position (1) to (3) and were kept there for nearly 2 hours without developing a pressure increase (Fig. 8) (Mapstone, 1976a ).
(4) The final pattern is shown in Fig. 14 (Fig. 15) . If at this point more pilocarpine and phenylephrine are instilled then in some eyes closed-angle glaucoma develops. Treatment moves the pupil back to position (1) and pressure returns to normal. This is the pilocarpine/ phenylephrine provocative test and has been discussed elsewhere (Mapstone, 1974 (Mapstone, , 1976 .
(6) Becker and Thompson (1958) showed that some angles can occlude on pupillary dilatation, yet no pressure increase is demonstrated. They suggested that this was because insufficient time had elapsed for pressure to increase. In a previous paper (Mapstone, 1977) it was shown that significant reductions in outflow can precede a rise in pressure. If the test is continued, almost complete angle closure and rise in pressure then occur. An extreme example is shown in Fig. 16 , where complete (gonioscopic) angle closure preceded a rise in pressure by 2 hours. No pressure increase is therefore compatible with angle closure and can occur as the pupil moves from (Fig. 11 ) position (1) to (2), at (2), and as the pupil moves from (3) to (2).
(7) The converse picture is provided by published reports (Lee, 1958; Hill, 1968; Haddad et al., 1970; Mapstone, 1974b) that phenylephrine can produce a significant increase in pressure yet the angle is unequivocally open to gonioscopy. This can occur in two situations: (a) A pupil moves (Fig. 11) from (1) (Fig. 13 ) from (3) down to (1), developing a raised pressure on the way. At (1) the angle is open and the paradox again present. A conventional gonioscopic interpretation would allow of no logical explanation. But by taking into account pupillary position and antecedent activity a ready interpretation is possible. The patient described by Mapstone (1974b) has had a peripheral iridectomy; reprovocation with phenylephrine subsequently produced no increase in pressure.
On the basis of the observations detailed above, therefore, it is suggested that the dilatation of narrow-angle eyes, for fundus inspection, be determined by the following considerations:
(1) Eyes at risk to the development of closed-angle glaucoma should never be dilated with cyclopentolate. If they are, then a minimum period of 24 hours' observation in hospital is necessary. Prescribing acetazolamide does not prevent angle closure (Mapstone, 1974) .
(2) A pupil dilated to wide mydriasis by phenylephrine is in a safe position. Miosis with pilocarpine is highly dangerous, and a significant proportion of eyes at risk will develop closed-angle glaucoma. On the other hand miosis with thymoxamine is safe, since it is complete within J hour (Mapstone, 1970 (Mapstone, , 1974 . This method has been used in more than I 4000 eyes to date without the development of acute glaucoma.
(3) Tropicamide mydriasis is safe if the following procedure is adopted: (a) All eyes at risk can be dilated with tropicamide if the patient is observed for 1 hour after instillation of drops. (b) If pressure has not risen significantly within 1 hour, the probabilities of that event occurring are low indeed (not once in 58 eyes at risk). (c) As soon as pressure increases significantly intravenous acetazolamide 500 mg and pilocarpine 2 % x 1 rapidly returns pressure to normal levels (usually in just over the hour, never longer than Ij hours). This is so with tropicamide because angle closure is rarely complete, and significant outflow facilities remain in the presence of a raised pressure.
(4) Finally, a raised pressure caused by an angleclosing mechanism is quite compatible with a (gonioscopically) open angle. So, too, is a (gonioscopically) closed angle compatible with no pressure increase. What has happened and is happening to the pupil, and for how long, are the important considerations.
